Pfizer jab lowers infection risk by 93% in adolescents, Israelis find
Three-month study confirms Pfizer’s effectiveness against the deadly Delta variant
20 October 2021 - 23:02
The launch of vaccinations for 12- to 17-year-olds on Wednesday coincided with new findings that the Pfizer/BioNTech vaccine significantly decreases symptomatic Covid-19 in adolescents...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.